Chimpanzees as an animal model for human norovirus infection and vaccine development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 1, 2011, Pages 325-330

  Bok, Karin ^a   Parra, Gabriel I ^a   Mitra, Tanaji ^a   Abente, Eugenio ^a   Shaver, Charlene K ^b   Boon, Denali ^a   Engle, Ronald ^a   Yu, Claro ^a   Kapikian, Albert Z ^a   Sosnovtsev, Stanislav V ^a   Purcell, Robert H ^a   Green, Kim Y ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BIOQUAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOROVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMPANZEE; DUODENUM; IMMUNOGENICITY; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PRIORITY JOURNAL; VACCINATION; VIRAL GASTROENTERITIS; VIRUS INFECTION; VIRUS LIKE AGENT;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GASTROENTERITIS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; INTESTINE, SMALL; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; NORWALK VIRUS; PAN TROGLODYTES; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES;

ANIMALIA; NOROVIRUS; NORWALK VIRUS; PAN;

EID: 78651063204     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1014577107     Document Type: Article

References (49)

1. Anonymous; Centers for Disease Control and Prevention (CDC) (2009) Surveillance for foodborne disease outbreaks - United States, 2006. MMWR Morb Mortal Wkly Rep 58:609-615.
2. Patel MM, et al. (2008) Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14:1224-1231.
3. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Estes MK (2003) Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol 108:241-247.
4. Dolin R, et al. (1972) Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med 140:578-583.
5. Dolin R, et al. (1971) Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis 123:307-312.
6. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR (1977) Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 297:86-89.
7. Wyatt RG, et al. (1974) Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis 129:709-714.
8. Green KY (2007) Caliciviridae: The noroviruses. Fields' Virology, eds Knipe DM, et al. (Lippincott Williams and Wilkins, Philadelphia), 5th Ed, Vol 1, pp 949-979.
9. Huang P, et al. (2003) Noroviruses bind to human ABO, Lewis, and secretor histoblood group antigens: Identification of 4 distinct strain-specific patterns. J Infect Dis 188:19-31.
10. Cao S, et al. (2007) Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 81:5949-5957.
11. Choi JM, Hutson AM, Estes MK, Prasad BV (2008) Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA 105:9175-9180.
12. Cheetham S, et al. (2006) Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol 80:10372-10381.
13. Rockx BH, Bogers WM, Heeney JL, van Amerongen G, Koopmans MP (2005) Experimental norovirus infections in non-human primates. J Med Virol 75:313-320.
14. Souza M, Cheetham SM, Azevedo MS, Costantini V, Saif LJ (2007) Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). J Virol 81:9183-9192.
15. Subekti DS, et al. (2002) Experimental infection of Macaca nemestrina with a Toronto Norwalk-like virus of epidemic viral gastroenteritis. J Med Virol 66:400-406.
16. Wyatt RG, et al. (1978) Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis. J Med Virol 2:89-96.
17. Dienstag JL, et al. (1975) Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis 132:532-545.
18. Purcell RH, Emerson SU (2001) Animal models of hepatitis A and E. ILAR J 42:161-177.
19. Feinstone SM, Daemer RJ, Gust ID, Purcell RH (1983) Live attenuated vaccine for hepatitis A. Dev Biol Stand 54:429-432.
20. Karron RA, et al. (1988) Studies of prototype live hepatitis A virus vaccines in primate models. J Infect Dis 157:338-345.
21. Purcell RH, et al. (1992) Inactivated hepatitis A vaccine: Active and passive immunoprophylaxis in chimpanzees. Vaccine 10(Suppl 1):S148-S151.
22. Goncalvez AP, et al. (2008) Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J Virol 82:7009-7021.
23. Lai CJ, et al. (2007) Epitope determinants of a chimpanzee dengue virus type 4 (DENV- 4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody. J Virol 81:12766-12774.
24. Chen Z, et al. (2007) Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J Virol 81:8989-8995.
25. Chen Z, et al. (2006) Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc Natl Acad Sci USA 103:1882-1887.
26. Schofield DJ, Glamann J, Emerson SU, Purcell RH (2000) Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 74:5548-5555.
27. Yanagi M, Purcell RH, Emerson SU, Bukh J (1997) Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94:8738-8743.
28. Cohen JI, Feinstone S, Purcell RH (1989) Hepatitis A virus infection in a chimpanzee: Duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis 160: 887-890.
29. Purcell RH, et al. (1987) Experimental hepatitis delta virus infection in the chimpanzee. Prog Clin Biol Res 234:27-36.
30. Sly DL, London WT, Purcell RH (1979) Illness in a chimpanzee inoculated with hepatitis B virus. J Am Vet Med Assoc 175:987-988.
31. Purcell RH, Wong DC, Shapiro M (2002) Relative infectivity of hepatitis A virus by the oral and intravenous routes in 2 species of nonhuman primates. J Infect Dis 185: 1668-1671.
32. Guo M, et al. (2001) Comparative pathogenesis of tissue culture-adapted and wildtype Cowden porcine enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by intravenous inoculation of wild-type PEC. J Virol 75:9239-9251.
33. Souza M, Azevedo MS, Jung K, Cheetham S, Saif LJ (2008) Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J Virol 82:1777-1786.
34. Lay MK, et al. (2010) Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology 406: 1-11.
35. LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS (2009) Alphavirus-adjuvanted norovirus-like particle vaccines: Heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J Virol 83:3212-3227.
36. Souza M, Costantini V, Azevedo MS, Saif LJ (2007) A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model. Vaccine 25:8448-8459.
37. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76: 12335-12343.
38. Lindesmith LC, et al. (2010) Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol 84:1800-1815.
39. Atmar RL, et al. (2008) Norwalk virus shedding after experimental human infection. Emerg Infect Dis 14:1553-1557.
40. Takanashi S, et al. (2009) Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J Clin Virol 44:161-163.
41. van Kooyk Y, Geijtenbeek TB (2003) DC-SIGN: Escape mechanism for pathogens. Nat Rev Immunol 3:697-709.
42. Siebenga JJ, et al. (2008) High prevalence of prolonged norovirus shedding and illness among hospitalized patients: A model for in vivo molecular evolution. J Infect Dis 198: 994-1001.
43. Tan M, et al. (2003) Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: Evidence for a binding pocket. J Virol 77:12562-12571.
44. Kapikian AZ, et al. (1972) Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 10: 1075-1081.
45. Teunis PF, et al. (2008) Norwalk virus: How infectious is it? J Med Virol 80:1468-1476.
46. Jiang X, Wang M, Graham DY, Estes MK (1992) Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66:6527-6532.
47. Prasad BV, et al. (1999) X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290.
48. Bok K, et al. (2009) Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 83:11890-11901.
49. Biesova Z, et al. (2009) Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/ Vietnam/1203/2004 influenza virus. Vaccine 27:6234-6238.